Assessment of the in vitro cytotoxicity and in vivo anti-tumor activity of the alcoholic stem bark extract/fractions of Mimusops elengi Linn.

Abstract

Various parts of Mimusops elengi Linn. (Sapotaceae) have been used widely in traditional Indian medicine for the treatment of pain, inflammation and wounds. The study was conducted to explore the use of stem bark of M. elengi on pharmacological grounds and to evaluate the scientific basis of cytotoxic and anti-tumor activity. Extract/fractions were prepared and in vitro cytotoxicity was assessed using SRB assay. Most effective fractions were subjected to fluorescence microscopy based acridine orange/ethidium bromide (AO/EB) and Hoechst 33342 staining to determine apoptosis induction and DNA fragmentation assay. Comet and micronuclei assay were performed to assess genotoxicity. Cell cycle analysis was also performed. In vivo anti-tumor potential was evaluated by Ehrlich ascites carcinoma (EAC) model in mice. The alcoholic stem bark extract of M. elengi along with four fractions showed potential in vitro cytotoxicity in SRB assay. Of these, dichloromethane and ethyl acetate fractions were selected for further studies. The fractions revealed apoptosis inducing potential in AO/EB and Hoechst 33342 staining, which was further confirmed by DNA fragmentation assay. Genotoxic potential was revealed by comet and micronuclei assay. Fractions also exhibited specific cell cycle inhibition in G 0 /G 1 phase. In EAC model, ethyl acetate fraction along with the standard (cisplatin) effectively reduced the increase in body weight compared to control and improved mean survival time. Both fractions were able to restore the altered hematological and biochemical parameters. Hence, M. elengi stem bark may be a possible therapeutic candidate having cytotoxic and anti-tumor potential.

Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells

“…Therefore, we observed that the combinatorial treatments of DOX with CQ and/or TIC increased MST (25~30 days), ILS% (60~90%) of MCF-7 tumor inoculated mammary mice when compared with untreated mice than either compared with control or dox treated groups ( Figure 2II-C). This is consistent with a study that reported the combinatorial treatments to be more effective as a significant reduction in tumor size with a prolonged life span, which was a significant criterion in determining the anticancer compound's effectiveness [35].…”

The Effects of Combining Cancer Drugs with Compounds Isolated from Combretum zeyheri Sond. and Combretum platypetalum Welw. ex M.A. Lawson (Combretaceae) on the Viability of Jurkat T Cells and HL-60 Cells

“…Toxicological studies are usually done to predict the potential toxicity of the drug during drug development [ 49 ]. Toxicological evaluation of the combination of CP 404 and chlorambucil was carried out using mouse peritoneal cells as this combination showed the highest antiproliferative effects on Jurkat T cells.…”

Determination of the Cytotoxic Effect of Different Leaf Extracts from Parinari curatellifolia (Chrysobalanaceae)

“…Cytotoxicity is generally used to predict potential toxicity using cultured cells that may be normal or transformed cells such as mouse peritoneal cells [ 41 ]. The test typically involves short-term exposure of cultured cells to test compounds to identify how the compound may affect basal or specialised cell functions, before performing toxicological studies in whole organisms.…”